Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs

Gastroenterology

Volumn 140, Issue 3, 2011, Pages 799-808.e2

  Chan, Andrew T ^a,b   Ogino, Shuji ^c,d   Giovannucci, Edward L ^b,e   Fuchs, Charles S ^b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chemoprevention; Colon Cancer; Inflammation; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CALCIUM; FOLIC ACID; IBUPROFEN; INTERLEUKIN 6; MULTIVITAMIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHEMOPROPHYLAXIS; COLORECTAL CANCER; COLORECTAL INFLAMMATION; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFICACY; FEMALE; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT RESPONSE;

EID: 79952284479     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.11.041     Document Type: Article

References (59)

1. A.T. Chan, E.L. Giovannucci, and J.A. Meyerhardt Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer JAMA 294 2005 914 923 (Pubitemid 41215460)
2. A.T. Chan, E.L. Giovannucci, and J.A. Meyerhardt Aspirin dose and duration of use and risk of colorectal cancer in men Gastroenterology 134 2008 21 28 (Pubitemid 350309311)
3. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 N Engl J Med 356 2007 2131 2142 (Pubitemid 47010839)
4. B.F. Cole, R.F. Logan, and S. Halabi Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials J Natl Cancer Inst 101 2009 256 266
5. M.V. Grau, R.S. Sandler, and G. McKeown-Eyssen Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study J Natl Cancer Inst 101 2009 267 276
6. D. Schottenfeld, and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia CA Cancer J Clin 56 2006 69 83
7. J. Terzic, S. Grivennikov, and E. Karin Inflammation and colon cancer Gastroenterology 138 2010 2101 2114 e5
8. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
9. J. Ventre, T. Doebber, and M. Wu Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice Diabetes 46 1997 1526 1531 (Pubitemid 27369096)
10. F.B. Hu, J.B. Meigs, and T.Y. Li Inflammatory markers and risk of developing type 2 diabetes in women Diabetes 53 2004 693 700 (Pubitemid 38270639)
11. S. Liu, L. Tinker, and Y. Song A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women Arch Intern Med 167 2007 1676 1685 (Pubitemid 47280350)
12. J.K. Pai, T. Pischon, and J. Ma Inflammatory markers and the risk of coronary heart disease in men and women N Engl J Med 351 2004 2599 2610 (Pubitemid 39628581)
13. F.B. Hu, J.E. Manson, and S. Liu Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women J Natl Cancer Inst 91 1999 542 547 (Pubitemid 29157063)
14. A.O. Chan, M.H. Jim, and K.F. Lam Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease JAMA 298 2007 1412 1419 (Pubitemid 47481607)
15. M.J. Gunter, R. Stolzenberg-Solomon, and A.J. Cross A prospective study of serum C-reactive protein and colorectal cancer risk in men Cancer Res 66 2006 2483 2487
16. T.P. Erlinger, E.A. Platz, and N. Rifai C-reactive protein and the risk of incident colorectal cancer JAMA 291 2004 585 590 (Pubitemid 38500312)
17. T. Otani, M. Iwasaki, and S. Sasazuki Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study Cancer Epidemiol Biomarkers Prev 15 2006 690 695
18. D. Il'yasova, L.H. Colbert, and T.B. Harris Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort Cancer Epidemiol Biomarkers Prev 14 2005 2413 2418 (Pubitemid 41437845)
19. D. Trichopoulos, T. Psaltopoulou, and P. Orfanos Plasma C-reactive protein and risk of cancer: a prospective study from Greece Cancer Epidemiol Biomarkers Prev 15 2006 381 384 (Pubitemid 43348407)
20. K. Aleksandrova, M. Jenab, and H. Boeing Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition Am J Epidemiol 172 2010 407 418
21. C. Siemes, L.E. Visser, and J.W. Coebergh C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study J Clin Oncol 24 2006 5216 5222 (Pubitemid 46631365)
22. K. Heikkila, R. Harris, and G. Lowe Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis Cancer Causes Control 20 2009 15 26
23. K.H. Allin, S.E. Bojesen, and B.G. Nordestgaard Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer J Clin Oncol 27 2009 2217 2224
24. Y. Ito, K. Suzuki, and K. Tamakoshi Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study J Epidemiol 15 Suppl 2 2005 S185 S189
25. K.H. Allin, B.G. Nordestgaard, and J. Zacho C-reactive protein and the risk of cancer: a mendelian randomization study J Natl Cancer Inst 102 2010 202 206
26. S.M. Zhang, J.E. Buring, and I.M. Lee C-reactive protein levels are not associated with increased risk for colorectal cancer in women Ann Intern Med 142 2005 425 432
27. S.E. Hankinson, W.C. Willett, and J.E. Manson Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women J Natl Cancer Inst 87 1995 1297 1302
28. D.J. Hunter, S.E. Hankinson, and H. Hough A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer Carcinogenesis 18 1997 2127 2132 (Pubitemid 28134739)
29. M.J. Stampfer, W.C. Willett, and F.E. Speizer Test of the National Death Index Am J Epidemiol 119 1984 837 839 (Pubitemid 14142821)
30. J.W. Rich-Edwards, K.A. Corsano, and M.J. Stampfer Test of the National Death Index and Equifax Nationwide Death Search Am J Epidemiol 140 1994 1016 1019 (Pubitemid 24373006)
31. J.K. Pai, G.C. Curhan, and C.C. Cannuscio Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection Clin Chem 48 2002 1781 1784
32. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin use and survival after diagnosis of colorectal cancer JAMA 302 2009 649 658
33. P.M. Ridker, C.H. Hennekens, and N. Rifai Hormone replacement therapy and increased plasma concentration of C-reactive protein Circulation 100 1999 713 716 (Pubitemid 29383640)
34. S. Durrleman, and R. Simon Flexible regression models with cubic splines Stat Med 8 1989 551 561 (Pubitemid 19116001)
35. Y. Baba, K. Nosho, and K. Shima Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer Clin Cancer Res 15 2009 4665 4673
36. E.W. Karlson, S.C. Chang, and J. Cui Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis Ann Rheum Dis 69 2009 54 60
37. K.J. Rothman, S. Greenland, and T.L. Lash Modern epidemiology 2008 Wolters Kluwer Health/Lippincott Williams & Wilkins Philadelphia, PA
38. M. Lundberg, P. Fredlund, and J. Hallqvist A SAS program calculating three measures of interaction with confidence intervals Epidemiology 7 1996 655 656
39. T. Andersson, L. Alfredsson, and H. Kallberg Calculating measures of biological interaction Eur J Epidemiol 20 2005 575 579 (Pubitemid 41126030)
40. P.M. Ridker, C.H. Hennekens, and J.E. Buring C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843 (Pubitemid 30165206)
41. W.E. Naugler, T. Sakurai, and S. Kim Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124 (Pubitemid 47056470)
42. I. Shai, M.B. Schulze, and J.E. Manson A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes Diabetes Care 28 2005 1376 1382 (Pubitemid 40756700)
43. A. Diez-Ruiz, G.P. Tilz, and R. Zangerle Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis Eur J Haematol 54 1995 1 8
44. R. DeRijk, D. Michelson, and B. Karp Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6 J Clin Endocrinol Metab 82 1997 2182 2191 (Pubitemid 27287581)
45. M. Ohgushi, A. Taniguchi, and M. Fukushima Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes mellitus Metabolism 56 2007 571 577 (Pubitemid 46427856)
46. G.S. Hotamisligil, P. Arner, and R.L. Atkinson Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance Diabetes 46 1997 451 455 (Pubitemid 27090275)
47. D. Aderka The potential biological and clinical significance of the soluble tumor necrosis factor receptors Cytokine Growth Factor Rev 7 1996 231 240 (Pubitemid 27200307)
48. K.E. de Visser, A. Eichten, and L.M. Coussens Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 2006 24 37 (Pubitemid 43053650)
49. M.L. Slattery, W. Samowitz, and M. Hoffman Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway Cancer Epidemiol Biomarkers Prev 13 2004 538 545 (Pubitemid 38737888)
50. S. Kim, T.O. Keku, and C. Martin Circulating levels of inflammatory cytokines and risk of colorectal adenomas Cancer Res 68 2008 323 328 (Pubitemid 351380135)
51. G.Y. Ho, X. Xue, and M. Cushman Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas J Natl Cancer Inst 101 2009 1650 1654
52. J.A. Baron, B.F. Cole, and R.S. Sandler A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 2003 891 899 (Pubitemid 36297997)
53. E. Flossmann, and P.M. Rothwell Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies Lancet 369 2007 1603 1613 (Pubitemid 46710123)
54. E.A. Platz, S. Sutcliffe, and A.M. De Marzo Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies Cancer Causes Control 21 2010 847 851
55. R. Clarke, M. Shipley, and S. Lewington Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies Am J Epidemiol 150 1999 341 353 (Pubitemid 29383482)
56. A.T. Chan, E.L. Giovannucci, and E.S. Schernhammer A prospective study of aspirin use and the risk of colorectal adenoma Ann Intern Med 140 2004 157 166
57. A.T. Chan, J.E. Manson, and D. Feskanich Long-term aspirin use and mortality in women Arch Intern Med 167 2007 562 572 (Pubitemid 46513225)
58. A.T. Chan, J.E. Manson, and C.M. Albert Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events Circulation 113 2006 1578 1587 (Pubitemid 43739417)
59. E.S. Huang, L.L. Strate, and W.W. Ho Long-term use of aspirin and the risk of gastrointestinal bleeding in a prospective, population-based cohort Gastroenterology 138 2010 S64